Naoto Kawakami

Naoto Kawakami

Auto-generated profile, based on publicly available information

Naoto Kawakami

Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München, Munich, Germany

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2009 in Nature
Verified
Journal Article
Closed access
IBIngo Bartholomäus
Ingo Bartholomäus
NKNaoto Kawakami
Naoto Kawakami
FOFrancesca Odoardi
Francesca Odoardi
CSChristian Schläger
Christian Schläger
DMDjordje Miljkovic
Djordje Miljkovic
AFAlexander Flügel
Alexander Flügel

1 January 2017 in Immunity
Verified
Journal Article
Open access
DDDavid Druzd
David Druzd
OMOlga Matveeva
Olga Matveeva
LILouise Ince
Louise Ince
UHUte Harrison
Ute Harrison
WHWenyan He
Wenyan He
CSChristoph Scheiermann
Christoph Scheiermann
Lymphocytes circulate through lymph nodes (LN) in search for antigen in what is believed to be a continuous process. Here, we show that lymphocyte migration through lymph nodes and lymph occurred in a non-continuous, circadian manner. Lymphocyte homing to lymph nodes peaked at night onset, with cells leaving the tissue during the day. This resulted in strong oscillations in lymphocyte cellularity in lymph nodes and efferent lymphatic fluid. Using lineage-specific genetic ablation of circadian clock function, we demonstrated this to be dependent on rhythmic expression of promigratory factors on lymphocytes. Dendritic cell numbers peaked in phase with lymphocytes, with diurnal oscillations being present in disease severity after immunization to induce experimental autoimmune encephalomyelitis (EAE). These rhythms were abolished by genetic disruption of T cell clocks, demonstrating a circadian regulation of lymphocyte migration through lymph nodes with time-of-day of immunization being critical for adaptive immune responses weeks later.

4 December 2012 in Neurology
Verified
Journal Article
Closed access
PDF file
JNJudy King Man Ng
Judy King Man Ng
JMJoachim Malotka
Joachim Malotka
NKNaoto Kawakami
Naoto Kawakami
TDTobias Derfuss
Tobias Derfuss
MKMohsen Khademi
Mohsen Khademi
EMEdgar Meinl
Edgar Meinl
Objectives: We asked whether autoantibodies against neurofascin (NF)186 or NF155, both localized at the nodes of Ranvier, are present in serum of patients with inflammatory neuropathy, and whether NF-specific monoclonal antibodies are pathogenic in vivo. Methods: We cloned human NF155 and NF186, and developed an ELISA and cell-based assay to screen for antibodies to human NF in a total of 434 donors including 294 patients with Guillain-Barré syndrome variants acute inflammatory demyelinating polyneuropathy (AIDP), acute motor axonal neuropathy, and chronic inflammatory demyelinating polyneuropathy (CIDP). We characterized reactive samples by isotyping, tissue section staining, and epitope mapping. We also injected NF-specific monoclonal antibodies IV into rats with experimental autoimmune neuritis. Results: We detected autoantibodies to NF by ELISA in 4% of patients with AIDP and CIDP, but not in controls. Most positive samples contained immunoglobulin G (IgG)1, IgG3, or IgG4 antibodies directed to only one isoform of NF. Two patients with CIDP showed particularly high (1:10,000 dilution) NF155-specific reactivity in both assays and stained paranodes. Two other patients with CIDP who benefited from plasma exchange exhibited antibodies to NF155 by ELISA, and upon affinity purification, antibodies to both isoforms were observed by both assays. Anti-NF monoclonal antibodies enhanced and prolonged induced neuritis in rats. Conclusions: Autoantibodies to NF are detected in a very small proportion of patients with AIDP and patients with CIDP, but may nevertheless be pathogenic in these cases.

6 June 2005 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
NKNaoto Kawakami
Naoto Kawakami
UNU. Valentin Nägerl
U. Valentin Nägerl
FOFrancesca Odoardi
Francesca Odoardi
TBTobias Bonhoeffer
Tobias Bonhoeffer
HWHartmut Wekerle
Hartmut Wekerle
AFAlexander Flügel
Alexander Flügel
We tracked pathogenic myelin basic protein-specific CD4+ effector T cells in early central nervous system (CNS) lesions of experimental autoimmune encephalomyelitis (EAE) by combining two-photon imaging and fluorescence video microscopy. We made two key observations: (a) the majority of the cells (65%) moved fast (maximal speed 25 μm/min) and apparently nondirected through the compact tissue; and (b) a second group of effector T cells (35%) appeared tethered to a fixed point. Polarization of T cell receptor and adhesion molecules (lymphocyte function-associated antigen 1) towards this fixed point suggests the formation of immune synapses. Nonpathogenic, ovalbumin-specific T cells were not tethered in the CNS and did not form synapse-like contacts, but moved through the tissue. After intrathecal injection of antigen, 40% of ovalbumin-specific T cells became tethered. Conversely, injection of anti–major histocompatibility complex class II antibodies profoundly reduced the number of stationary pathogenic T cells within the CNS (to 15%). We propose that rapid penetration of the CNS parenchyma by numerous autoimmune effector T cells along with multiple autoantigen-presentation events are responsible for the fulminate development of clinical EAE.

1 August 2018 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
MSMelania Spadaro
Melania Spadaro
SWStephan Winklmeier
Stephan Winklmeier
EBEduardo Beltrán
Eduardo Beltrán
CMCaterina Macrini
Caterina Macrini
RHRomana Höftberger
Romana Höftberger
EMEdgar Meinl
Edgar Meinl

19 January 2004 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
NKNaoto Kawakami
Naoto Kawakami
SLSilke Lassmann
Silke Lassmann
ZLZhaoxia Li
Zhaoxia Li
FOFrancesca Odoardi
Francesca Odoardi
TRThomas Ritter
Thomas Ritter
AFAlexander Flügel
Alexander Flügel
The clinical picture of experimental autoimmune encephalomyelitis (EAE) is critically dependent on the nature of the target autoantigen and the genetic background of the experimental animals. Potentially lethal EAE is mediated by myelin basic protein (MBP)–specific T cells in Lewis rats, whereas transfer of S100β- or myelin oligodendrocyte glycoprotein (MOG)–specific T cells causes intense inflammatory response in the central nervous system (CNS) with minimal disease. However, in Dark Agouti rats, the pathogenicity of MOG-specific T cells resembles the one of MBP-specific T cells in the Lewis rat. Using retrovirally transduced green fluorescent T cells, we now report that differential disease activity reflects different levels of autoreactive effector T cell activation in their target tissue. Irrespective of their pathogenicity, the migratory activity, gene expression patterns, and immigration of green fluorescent protein+ T cells into the CNS were similar. However, exclusively highly pathogenic T cells were significantly reactivated within the CNS. Without local effector T cell activation, production of monocyte chemoattractants was insufficient to initiate and propagate a full inflammatory response. Low-level reactivation of weakly pathogenic T cells was not due to anergy because these cells could be activated by specific antigen in situ as well as after isolation ex vivo.